• 1
    Munkholm P. Crohn’s disease – occurrence, course and prognosis. An epidemiological cohort study. Dan Med Bull 1997; 44: 287302.
  • 2
    Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and foetal outcome. J Clin Gastroenterol 1984; 6: 2116.
  • 3
    Munkholm P. Pregnancy, fertility and disease course in patients with Crohn’s Disease and ulcerative colitis. Eur J Intern Med 2000; 11: 21521.
  • 4
    Moody GA, Probert C, Jayanthi V, Mayberry JF. The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire. Int J Colorectal Dis 1997; 12: 2204.
  • 5
    Narendranathan M, Sandler RS, Suchindran CM, Savitz DA. Male infertility in inflammatory bowel disease. J Clin Gastroenterol 1989; 11: 4036.
  • 6
    Alstead EM. Inflammatory bowel disease and pregnancy. Postgrad Med J 2002; 78: 236.
  • 7
    Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993; 54: 25660.
  • 8
    Levi AJ, Fisher AM, Hughes L, Henry WF. Male infertility due to sulphasalazine. Lancet 1979; 314: 2768.
  • 9
    O’Morain C, Smethurst P, Dore CJ, Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984; 25: 107884.
  • 10
    Cosentino MJ, Chey WY, Takihara H, Cockett AT. The effects of sulfasalazine on human male fertility potential and seminal prostaglandins. J Urol 1984; 132: 6826.
  • 11
    Toovey S, Hudson E, Hendry WF, Levi AJ. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut 1981; 22: 44551.
  • 12
    Caprilli R, Gassull MA, Escher JC, et al. European Crohn’s and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut 2006; 55(Suppl. 1): i3658.
  • 13
    Zelissen PM, Van Hattum J, Poen H, Scholten P, Gerritse R, Te Velde ER. Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones. Scand J Gastroenterol 1988; 23: 11004.
  • 14
    Balasubramanian K, Aruldhas MM, Govindarajulu P. Effect of corticosterone on rat epididymal lipids. J Androl 1987; 8: 6973.
  • 15
    Lerman SA, Miller GK, Bohlman K, et al. Effects of corticosterone on reproduction in male Sprague-Dawley rats. Reprod Toxicol 1997; 11: 799805.
  • 16
    Roberts AC, McClure RD, Weiner RI, Brooks GA. Overtraining affects male reproductive status. Fertil Steril 1993; 60: 68692.
  • 17
    Ligumsky M, Badaan S, Lewis H, Meirow D. Effects of 6-mercaptopurine treatment on sperm production and reproductive performance: a study in male mice. Scand J Gastroenterol 2005; 40: 4449.
  • 18
    Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000; 95: 6848.
    Direct Link:
  • 19
    Kane SV. What’s good for the goose should be good for the gander – 6-MP use in fathers with inflammatory bowel disease. Am J Gastroenterol 2000; 95: 581.
  • 20
    Dejaco C, Mittermaier C, Reinisch W, et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001; 121: 104853.
  • 21
    Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003; 124: 917.
  • 22
    Golby M. Fertility after renal transplantation. Transplantation 1970; 10: 2017.
  • 23
    Caprilli R, Angelucci E, Cocco A, et al. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Dig Liver Dis 2005; 37: 40717.
  • 24
    Hinkes E, Plotkin D. Reversible drug-induced sterility in a patient with acute leukemia. JAMA 1973; 223: 14901.
  • 25
    Sussman A, Leonard JM. Psoriasis, methotrexate, and oligospermia. Arch Dermatol 1980; 116: 2157.
  • 26
    Kim MM, Lee SH, Lee MG, Hwang SJ, Kim CK. Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats. Biopharm Drug Dispos 1995; 16: 27993.
  • 27
    Rutgeerts P, Van Assche G, Vermeire S. Review article: infliximab therapy for inflammatory bowel disease – seven years on. Aliment Pharmacol Ther 2006; 23: 45164.
  • 28
    D’haens G. Infliximab for ulcerative colitis: finally some answers. Gastroenterology 2005; 128: 21614.
  • 29
    Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 246276.
  • 30
    Treacy G. Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNF-α monoclonal antibody. Hum Exp Toxicol 2000; 19: 2268.
  • 31
    Hanauer S, Luká M, MacIntosh D, Rutgeerts P, Sandborn W, Pollack P. A randomized, double-blind, placebo-controlled trial of the human anti-TNF-α monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn’s disease. Gastroenterology 2004; 127: 332.
  • 32
    Hueting WE, Gooszen HG, Van Laarhoven CJ. Sexual function and continence after ileo pouch anal anastomosis: a comparison between a meta-analysis and a questionnaire survey. Int J Colorectal Dis 2004; 19: 2158.
  • 33
    Berndtsson I, Oresland T, Hulten L. Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study. Scand J Gastroenterol 2004; 39: 3749.
  • 34
    Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 1980; 21: 46974.
  • 35
    Khosla R, Willoughby CP, Jewell DP. Crohn’s disease and pregnancy. Gut 1984; 25: 526.
  • 36
    Fielding JF, Cooke WT. Pregnancy and Crohn’s disease. BMJ 1970; 2: 767.
  • 37
    De Dombal FT, Watts JM, Watkinson G, Goligher JC. Ulcerative colitis and pregnancy. Lancet 1965; 25: 599602.
  • 38
    Elbaz G, Fich A, Levy A, Holcberg G, Sheiner E. Inflammatory bowel disease and preterm delivery. Int J Gynaecol Obstet 2005; 90: 1937.
  • 39
    Sheiner E, Shoham-Vardi I, Hershkovitz R, Katz M, Mazor M. Infertility treatment is an independent risk factor for cesarean section among nulliparous women aged 40 and above. Am J Obstet Gynecol 2001; 185: 88892.
  • 40
    Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990; 99: 98794.
  • 41
    Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997; 58: 22937.
  • 42
    Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn’s disease: a case control study by European collaborative group. Gut 1986; 27: 8215.
  • 43
    Arkuran C, McComb P. Crohn’s disease and tubal infertility: the effect of adhesion formation. Clin Exp Obstet Gynecol 2000; 27: 123.
  • 44
    Penn I, Makowski E, Droegemueller W, Halgrimson CG, Starzl TE. Parenthood in renal homograft recipients. JAMA 1971; 216: 175561.
  • 45
    Gillibrand PN. Systemic lupus erythematosus in pregnancy treated with azathioprine. Proc R Soc Med 1966; 59: 834.
  • 46
    Darai E, Marpeau O, Thomassin I, Dubernard G, Barranger E, Bazot M. Fertility after laparoscopic colorectal resection for endometriosis: preliminary results. Fertil Steril 2005; 84: 94550.
  • 47
    Mohr C, Nezhat FR, Nezhat CH, Seidman DS, Nezhat CR. Fertility considerations in laparoscopic treatment of infiltrative bowel endometriosis. JSLS 2005; 9: 1624.
  • 48
    Coronado C, Franklin RR, Lotze EC, Bailey HR, Valdes CT. Surgical treatment of symptomatic colorectal endometriosis. Fertil Steril 1990; 53: 4116.
  • 49
    Ording Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002; 122: 159.
  • 50
    Olsen KO, Joelsson M, Laurberg S, Oresland T. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg 1999; 86: 4935.
  • 51
    Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004; 47: 111926.
  • 52
    Calderwood AH, Kane SV. IBD and pregnancy. MedGenMed 2004; 6: 14.
  • 53
    Beniada A, Benoist G, Maurel J, Dreyfus M. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod 2005; 34: 5818.
  • 54
    Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynaecol Obstet 2004; 270: 7985.
  • 55
    Miller JP. Inflammatory disease in pregnancy: a review. J R Soc Med 1986; 79: 2215.
  • 56
    Asimakopoulos G. Pregnancy and inflammatory bowel disease. Rev Med Chir Soc Med Nat Iasl 2004; 108: 4650.
  • 57
    Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Foetal Neonatal Med 2004; 15: 23741.
  • 58
    Woolfson K, Cohen Z, McLeod RS. Crohn’s disease and pregnancy. Dis Colon Rectum 1990; 33: 86973.
  • 59
    Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease – A population-based cohort study. Am J Obstet Gynecol 1997; 177: 9426.
  • 60
    Norgard B, Fonager K, Sorensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 2000; 95: 316570.
    Direct Link:
  • 61
    Lamah M, Scott HJ. Inflammatory bowel disease and pregnancy. Int J Colorectal Dis 2002; 17: 21622.
  • 62
    Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002; 97: 6418.
    Direct Link:
  • 63
    Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn’s disease. Scand J Gastroenterol 1984; 19: 72432.
  • 64
    Lene Riis, Ida Vind, Patrizia Politi, et al. On behalf of the European Collaborative study group on inflammatory bowel disease (EC-IBD). Does pregnancy change the disease course? A Study in a European Cohort of Patients with Inflammatory Bowel Disease. Am J Gastroenterol 2006; 101: 153945.
    Direct Link:
  • 65
    Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998; 93: 242630.
    Direct Link:
  • 66
    Schofield PF, Turnbull RB, Hawk WA. Crohn’s disease and pregnancy. BMJ 1970; 1: 364.
  • 67
    Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn’s disease, pregnancy and birth weight. Am J Gastroenterol 2000; 95: 10216.
    Direct Link:
  • 68
    Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 427.
  • 69
    Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol 1996; 20: 11526.
  • 70
    Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 1996; 110: 42431.
  • 71
    Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005; 100: 1025.
    Direct Link:
  • 72
    Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18: 73542.
  • 73
    Mogadam M, Korelitz BI, Ahmed SW, Dobbins WO, 3rd, Baiocco PJ. The course of inflammatory bowel disease during pregnancy and post partum. Am J Gastroenterol 1981a; 75: 2659.
  • 74
    Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998; 27: 21324.
  • 75
    Abramson D, Jankelson IR, Milner LR. Pregnancy in idiopathic ulcerative colitis. Am J Obstet Gynecol 1951; 61: 1219.
  • 76
    Ravid A, Richard CS, Spencer LM, et al. Pregnancy, delivery and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2002; 45: 12838.
  • 77
    Juhasz ES, Fozard B, Dozois RR, Ilstrup DM, Nelson H. Ileal pouch-anal anastomosis function following childbirth: an extended evaluation. Dis Colon Rectum 1995; 38: 15965.
  • 78
    Ilnyckyji A, Blanchard JF, Rawsthorne P, Bernstein CN. Perianal Crohn’s disease and pregnancy: role of the mode of delivery. Am J Gastroenterol 1999; 94: 32748.
    Direct Link:
  • 79
    Sultan AH, Kamm MA, Hudson CN, Thomas JM, Bartram CI. Anal-sphincter disruption during vaginal delivery. N Engl J Med 1993; 329: 190511.
  • 80
    Kitayama T, Funayama Y, Fukushima K, et al. Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis. Surg Today 2005; 35: 2115.
  • 81
    Remzi FH, Gorgun E, Bast J, et al. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 2005; 48: 16919.
  • 82
    Hahnloser D, Pemberton JH, Wolff BG, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum 2004; 47: 112735.
  • 83
    Homan WP, Thorbjarnarson B. Crohn disease and pregnancy. Arch Surg 1976; 111: 5457.
  • 84
    De Dombal FT, Burton IL, Goligher JC. Crohn’s disease and pregnancy. BMJ 1972; 3: 5503.
  • 85
    Katz JA. Pregnancy and inflammatory bowel disease. Curr Opin Gastroenterol 2004; 20: 32832.
  • 86
    Brandt LJ, Estabrook SG, Reinus JF. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn’s disease. Am J Gastroenterol 1995; 90: 191822.
  • 87
    Rogers RG, Katz VL. Course of Crohn’s disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol 1995; 12: 2624.
  • 88
    Weterman IT. Fertility and pregnancy in inflammatory bowel disease. Neth J Med 1989; 35(Suppl. 1): S6775.
  • 89
    Restellini A. Inflammatory diseases of the digestive system and pregnancy: clinical case and review of the literature. Schweiz Rundsch Med Prax 1989; 78: 5604.
  • 90
    Castiglione F, Pignata S, Morace F, et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 1996; 28: 199204.
  • 91
    Nwokolo CU, Tan WC, Andrews HA, Allan RN. Surgical resections in parous patients with distal ileal and colonic Crohn’s disease. Gut 1994; 35: 2203.
  • 92
    Subhani JM, Hamiliton MI. Review article: the management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther 1998; 12: 103954.
  • 93
    Cappell MS, Colon VJ, Sidhom OA. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci 1996; 41: 235361.
  • 94
    Katz JA. Endoscopy in the pregnancy patient with inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002; 12: 63646.
  • 95
    Mahadevan U, Kane S. American Gastroenterological Association Institute Technical Review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131: 283311.
  • 96
    Celleno D, Capogna G, Tomassetti M, Costantino P, Di Feo G, Nisini R. Neurobehavioural effects of propofol on the neonate following elective caesarean section. Br J Anaesth 1989; 62: 64954.
  • 97
    Yau G, Gin T, Ewart MC, Kotur CF, Leung RK, Oh TE. Propofol for induction and maintenance of anaesthesia at caesarean section. A comparison with thioprentone/enflurane. Anaesthesia 1991; 46: 203.
  • 98
    Abboud TK, Zhu J, Richardson M, Peres Da Silva E, Donovan M. Intravenous propofol vs thiamylai-isoflurane for caesarean section, comparative maternal and neonatal effects. Acta Anaesthesiol Scand 1995; 39: 2059.
  • 99
    Gregory MA, Gin T, Yau G, Leung RK, Chan K, Oh TE. Propofol infusion anaesthesia for caesarean section. Can J Anaesth 1990; 37: 51420.
  • 100
    Valtonen M, Kanto J, Rosenbery P. Comparison of propofol and thiopentone for induction of anesthesia for elective caesarean section. Anaesthesia 1989; 44: 75862.
  • 101
    Gint T, Gregory MA, Oh TE. The haemodynamic effects of propofol and thiopentone for induction anaesthesia for caesarean section. Anaesth Intensive Care 1990; 18: 1759.
  • 102
    Connell W, Miller A. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf 1999; 21: 31123.
  • 103
    O’Morain CA. Does nutritional therapy in inflammatory bowel disease have a primary or an adjunctive role? Scand J Gastroenterol Suppl 1990; 172: 2934.
  • 104
    O’Sullivan M, O’Morain C. Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2006; 20: 56173.
  • 105
    Teahon K, Pearson M, Levi AJ, Bjarnason I. Elemental diet in the management of Crohn’s disease during pregnancy. Gut 1991; 32: 107981.
  • 106
    Jarnerot G, Into-Malmberg MB, Esbjorner E. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scand J Gastroenterol 1981a; 16: 6937.
  • 107
    Gionchetti P, Campieri M, Belluzzi A, et al. Bioavailability of single and multiple doses of a new oral formulation of 5-ASA in patients with inflammatory bowel disease and healthy volunteers. Aliment Pharmacol Ther 1994; 8: 53540.
  • 108
    Jarnerot G, Andersen S, Esbjorner E, Sandstrom B, Brodersen R. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol 1981b; 16: 104955.
  • 109
    Esbjorner E, Jarnerot G, Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand 1987; 76: 13742.
  • 110
    Moskovitz DN, Bodian C, Chapman ML, et al. The effect on the foetus of medications used in pregnant inflammatory bowel disease patients. Am J Gastroenterol 2004; 99: 65661.
    Direct Link:
  • 111
    Mogadam M, Dobbins WO, 3rd, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981b; 80: 726.
  • 112
    Czeizel AE, Toth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996; 53: 64551.
  • 113
    Jansen G, Van der Heijden J, Oerlemans R, et al. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis. Arthritis Rheum 2004; 50: 21309.
  • 114
    Norgard B, Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001; 15: 4836.
  • 115
    Marteau P, Tennenbaum R, Elefant E, Lemann M, Cosnes J. Foetal outcome in women with IBD treated during pregnancy with oral mesalazine microgranules. Alim Pharmacol Ther 1998; 12: 11018.
  • 116
    Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998; 114: 238.
  • 117
    Colombel JF, Brabant G, Gubler MC, et al. Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet 1994; 344: 6201.
  • 118
    Marteau P, Seksik P, Beaugerie L, et al. Recommendations for clinical practice for the treatment of ulcerative colitis. Gastroenterol Clin Biol 2004; 28 (10 Pt. 2): 95560.
  • 119
    Rodriguez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998; 58: 25.
  • 120
    Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999; 86: 2424.
  • 121
    Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 38592.
  • 122
    Reinisch JM, Simon NG, Karow WG, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978; 202: 4368.
  • 123
    Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004; 18: 93101.
  • 124
    Gluck PA, Gluck JC. A review of pregnancy outcomes after exposure to orally inhaled budesonide. Curr Med Res Opin 2005; 21: 107584.
  • 125
    Rahimi R, Nikfar S, Abdollahi M. Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review. Hum Exp Toxicol 2006; 25: 44752.
  • 126
    Kihlstrom I, Lundberg C. Teratogenicity study of the new glucocorticoid budesonide in rabbits. Arzneimittelforschung 1987; 37: 436.
  • 127
    Padbury JF, Ervin MG, Polk DH. Extrapulmonary effects of antenatally administered steroids. J Pediatr 1996; 128: 16772.
  • 128
    Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res 1973; 7: 50919.
  • 129
    Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977; 127: 2647.
  • 130
    Petersen MC, Nation RL, Ashley JJ, McBride WG. The placental transfer of betamethasone. Eur J Clin Pharmacol 1980; 18: 2457.
  • 131
    Dancis J, Jansen V, Levitz M. Placental transfer of steroids: effect of binding to serum albumin and to placenta. Am J Physiol 1980; 238: E20813.
  • 132
    Polifka JE, Friedman JM. Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002; 65: 24061.
  • 133
    De Boer NK, Jarbandhan SV, De Graaf P, Mulder CJ, Van Elburg RM, Van Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 2006; 101: 13902.
    Direct Link:
  • 134
    De Boer NK, Van Elburg RM, Wilhelm AJ, et al. 6-Thioguanine for Crohn’s disease during pregnancy: thiopurine metabolite measurements in both mother and child. Scand J Gastroenterol 2005; 40: 13747.
  • 135
    Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000; 160: 6109.
  • 136
    Norgard B, Pedersen L, Fonager K, Rasmussen SN, Sorensen HT. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 2003; 17: 82734.
  • 137
    Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990; 99: 4436.
  • 138
    Oefferlbauer-Ernst A, Reinisch W, Miehsler W, Vogelsang H, Dejaco C. Healthy offspring in parents both receiving thiopurines. Gastroenterology 2004; 126: 628.
  • 139
    DeWitte DB, Buick MK, Cyran SE, Maisels MJ. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr 1984; 105: 6258.
  • 140
    Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynecol 1985; 92: 2339.
  • 141
    Milunsky A, Graef JW, Gaynor MF Jr. Methotrexate-induced congenital malformations. J Pediatr 1968; 72: 7905.
  • 142
    Bawle EV, Conard JV, Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology 1998; 57: 515.
  • 143
    Lipscomb GH, Givens VM, Meyer NL, Bran D. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy. Am J Obstet Gynecol 2005; 192: 18447.
  • 144
    Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology 1994; 49: 7981.
  • 145
    Albengres E, Le Louet H, Tillement JP. Immunosuppressive drugs and pregnancy: experimental and clinical data. Transplant Proc 1997; 29: 24616.
  • 146
    Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001; 71: 10515.
  • 147
    Anderson JB, Turner GM, Williamson RC. Fulminant ulcerative colitis in late pregnancy and the puerperium. J R Soc Med 1987; 80: 4924.
  • 148
    Jayaprakash A, Gould S, Lim AG, Shehata HA. Use of cyclosporin in pregnancy. Gut 2004; 53: 13867.
  • 149
    Angelberger S, Reinisch W, Dejaco C. Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy. Gut 2006; 55: 13645.
  • 150
    Dor R, Blanshard C. Caution with the use of cyclosporin in pregnancy. Gut 2003; 52: 1070.
  • 151
    Jain A, Venkataramanan R, Fung JJ, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997; 64: 55965.
  • 152
    Jain AB, Reyes J, Marcos A, et al. Pregnancy after liver transplantation with tacrolimus immunosppression: a single center’s experience update at 13 years. Transplantation 2003; 76: 82732.
  • 153
    Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000; 70: 171821.
  • 154
    Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study. Eur J Obstet Gynecol Reprod Biol 2001; 97: 18892.
  • 155
    Berkovitch M, Diav-Citrin O, Greenberg R, et al. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study. Br J Clin Pharmacol 2004; 58: 298302.
  • 156
    Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 1(2 Pt 1): 5259.
  • 157
    Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis Br J Clin Pharmacol 1997; 44: 17982.
  • 158
    Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993; 82: 34852.
  • 159
    Sorensen HT, Larsen H, Jensen ES, et al. Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. J Antimicrob Chemother 1999; 44: 8546.
  • 160
    Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 2001; 63: 18692.
  • 161
    Linseman DA, Hampton LA, Branstetter DG. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol 1995; 28: 5964.
  • 162
    Loebstein R, Addis A, Ho E, et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998; 42: 13369.
  • 163
    Larsen H, Nielsen GL, Schonheyder HC, Olesen C, Sorensen HT. Birth outcome following maternal use of fluoroquinolones. Int J Antimicrob Agents 2001; 18: 25962.
  • 164
    Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994; 84: 5358.
  • 165
    Einarson A, Mastroiacovo P, Arnon J, et al. Prospective, controlled, multicentre study of loperamide in pregnancy. Can J Gastroenterol 2000; 14: 1857.
  • 166
    Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician 2003; 67: 251724.
  • 167
    Collins E. Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 1981; 5(Suppl.): 57S62S.
  • 168
    Khanna D, McMahon M, Furst DE. Safety of tumour necrosis factor-alpha antagonists. Drug Saf 2004; 27: 30724.
  • 169
    Simister NE. Placental transport of immunoglobulin G. Vaccine 2003; 21: 33659.
  • 170
    Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of Pregnancy in women receiving infliximab for the treatment of Crohn’s disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 238592.
    Direct Link:
  • 171
    Lichtenstein G, Cohen RD, Feagan BG, et al. Safety of infliximab in Crohn’s disease: data from the 5000-patient TREAT Registry (abstr). Gastroenterology 2004; 126: A54.
  • 172
    Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn’s disease. Aliment Pharmacol Ther 2005; 21: 7338.
  • 173
    Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 2005; 54: 890.
  • 174
    Bergstrand O, Hellers G. Breast-feeding during infancy in patients who later develop Crohn’s disease. Scand J Gastroenterol 1983; 18: 9036.
  • 175
    Branski D, Kerem E, Gross-Kieselstein E, Hurvitz H, Litt R, Abrahamov A. Bloody diarrhea – a possible complication of sulfasalazine transferred through human breast milk. J Pediatr Gastroenterol Nutr 1986; 5: 3167.
  • 176
    Nelis G. Diarrhoea due to 5-aminosalicylic acid in breast milk. Lancet 1989; i: 383.
  • 177
    Silverman DA, Ford J, Shaw I, Probert CS. Is mesalazine really safe for use in breastfeeding mothers? Gut 2005; 54: 1701.
  • 178
    Christensen LA. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man. Dan Med Bull 2000; 47: 2041.
  • 179
    Jusko WJ. Pharmacokinetics and receptor-mediated pharmacodynamics of corticosteroids. Toxicology 1995; 102: 18996.
  • 180
    Committee on Drugs American Academy of Pediatrics. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 7769.
  • 181
    Matheson I, Lunde PK, Bredesen JE. Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol 1990; 30: 78793.
  • 182
    Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen TI, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324: 848.
  • 183
    Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998; 16: 3515.
  • 184
    Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn’s disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996; 111: 597603.
  • 185
    Montgomery SM, Lambe M, Wakefield AJ, Pounder RE, Ekbom A. Siblings and the riks of inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 13018.
  • 186
    Odes S. Changing epidemiology of ulcerative colitis and Crohn’s disease in Jews and Arabs in southern Israel. Gut 2003; 52(Suppl. VI): A39.
  • 187
    Russell RK, Farhadi R, Wilson M, Drummond H, Satsangi J, Wilson DC. Parental smoking during pregnancy and an atopic background predispose to paediatric inflammatory bowel disease. Gut 2005; 54(Suppl. II): A2.
  • 188
    Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke – a case-control study. Gut 1990; 31: 137781.
  • 189
    Sandler RS, Sandler DP, McDonnell CW, Wurzelmann JI. Childhood exposure to environmental tobacco smoke and the risk of ulcerative colitis. Am J Epidem 1992; 135: 6038.
  • 190
    Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol 2004; 18: 52539.
  • 191
    Faybush EM, Blanchard JF, Rawsthorne P, Bernstein CN. Generational differences in the age at diagnosis with IBD: genetic anticipation, bias or temporal effects. Am J Gastroenterol 2002; 97: 63640.
    Direct Link:
  • 192
    Flampe J, Heyman K, Kruis W, Raedler A, Folsch UR, Schreiber S. Anticipation in inflammatory bowel disease: a phenomenon caused by accumulation of confounders. Am J Med Genet 2000; 92: 17883.
  • 193
    Lee JC, Bridger S, Mc Gregor C, Macpherson AH, James JE. Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parents. Gut 1999; 44: 80811.
  • 194
    Van Ranst M, Joossens M, Joossens S, et al. Crohn’s disease and month of birth. Inflamm Bowel Dis 2005; 11: 5979.
  • 195
    Pardi DS, Tremaine WJ, Sandborn WJ, Loftus EV Jr, Poland GA, Melton LJ, 3rd. Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease. Inflamm Bowel Dis 1999; 5: 1046.
  • 196
    Administration FDA. Regulations 1980; 44: 3743467.